Beam Therapeutics, Inc. (BEAM)
24.66
+0.44
(+1.82%)
USD |
NASDAQ |
Apr 02, 16:00
24.66
0.00 (0.00%)
After-Hours: 20:00
Beam Therapeutics Research and Development Expense (TTM) : 409.62M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Intellia Therapeutics, Inc. | 379.07M |
| Twist Bioscience Corp. | 76.11M |
| Pacific Biosciences of California, Inc. | 95.21M |
| Ionis Pharmaceuticals, Inc. | 914.12M |
| Stryker Corp. | 1.567B |